COVID-19 for the Cardiologist Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies

被引:218
作者
Atri, Deepak [1 ]
Siddiqi, Hasan K. [1 ]
Lang, Joshua P. [1 ]
Nauffal, Victor [1 ]
Morrow, David A. [1 ]
Bohula, Erin A. [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, 350 Longwood Ave,First Off Floor, Boston, MA 02115 USA
来源
JACC-BASIC TO TRANSLATIONAL SCIENCE | 2020年 / 5卷 / 05期
关键词
cardiovascular; COVID-19; SARS-CoV-2; treatments; virology; ACUTE-RESPIRATORY-SYNDROME; CONVERTING ENZYME 2; TUMOR-NECROSIS-FACTOR; CORONAVIRUS SARS-COV; TISSUE FACTOR; FUNCTIONAL RECEPTOR; SPIKE PROTEIN; FACTOR-ALPHA; TNF-ALPHA; INFLAMMATION;
D O I
10.1016/j.jacbts.2020.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease-2019 (COVID-19), a contagious disease caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has reached pandemic status. As it spreads across the world, it has overwhelmed health care systems, strangled the global economy, and led to a devastating toss of life. Widespread efforts from regulators, clinicians, and scientists are driving a rapid expansion of knowledge of the SARS-CoV-2 virus and COVID-19. The authors review the most current data, with a focus on the basic understanding of the mechanism(s) of disease and translation to the clinical syndrome and potential therapeutics. The authors discuss the basic virology, epidemiology, clinical manifestation, muttiorgan consequences, and outcomes. With a focus on cardiovascular complications, they propose several mechanisms of injury. The virology and potential mechanism of injury form the basis for a discussion of potential disease-modifying therapies. (C) 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation.
引用
收藏
页码:518 / 536
页数:19
相关论文
共 164 条
[21]   Expression, purification, and characterization of SARS coronavirus RNA polymerase [J].
Cheng, A ;
Zhang, W ;
Xie, YH ;
Jiang, WH ;
Arnold, E ;
Sarafianos, SG ;
Ding, JP .
VIROLOGY, 2005, 335 (02) :165-176
[22]  
Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005
[23]  
Clerkin KJ, 2020, Circulation
[24]  
Committee on Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations
[25]  
Institute of Medicine, 2012, CRISIS STANDARDS CAR
[26]   Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease [J].
Corrales-Medina, Vicente F. ;
Alvarez, Karina N. ;
Weissfeld, Lisa A. ;
Angus, Derek C. ;
Chirinos, Julio A. ;
Chang, Chung-Chou H. ;
Newman, Anne ;
Loehr, Laura ;
Folsom, Aaron R. ;
Elkind, Mitchell S. ;
Lyles, Mary F. ;
Kronmal, Richard A. ;
Yende, Sachin .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (03) :264-274
[27]   Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation [J].
Cox, D. ;
Kerrigan, S. W. ;
Watson, S. P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (06) :1097-1107
[28]   Angiotensin-converting enzyme 2 is an essential regulator of heart function [J].
Crackower, MA ;
Sarao, R ;
Oudit, GY ;
Yagil, C ;
Kozieradzki, I ;
Scanga, SE ;
Oliveira-dos-Santos, AJ ;
da Costa, J ;
Zhang, LY ;
Pei, Y ;
Scholey, J ;
Ferrario, CM ;
Manoukian, AS ;
Chappell, MC ;
Backx, PH ;
Yagil, Y ;
Penninger, JM .
NATURE, 2002, 417 (6891) :822-828
[29]   Origin and evolution of pathogenic coronaviruses [J].
Cui, Jie ;
Li, Fang ;
Shi, Zheng-Li .
NATURE REVIEWS MICROBIOLOGY, 2019, 17 (03) :181-192
[30]   Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects [J].
de Jonge, E ;
Friederich, PW ;
Vlasuk, GP ;
Rote, WE ;
Vroom, MB ;
Levi, M ;
Van der Poll, T .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (03) :495-497